42 h. ago World’s first ‘ethical AI’ wades into risks of China’s new drug abuse law

A new Chinese AI system called Wen Dao – billed as the world’s first such model to be designed explicitly for ethical risk detection – has landed in the middle of its first major moral dilemma. Its immediate challenge is to navigate one of 2025’s most explosive social debates: whether the country should automatically seal the records of convicted drug users under the newly revised Public Security Administration Punishments Law. Effective January 1, an amendment to the law known as Article 136...

Events

49 h. ago How China went from generic drug factory to biomedicine innovator

China’s pharmaceutical industry is on the brink of enormous growth and transformation. In just a few years, it has moved on from being the world’s cheapest source of active pharmaceutical ingredients to becoming a major hub for pharmaceutical innovation – a place where new, more effective drugs are born. It is now the second-largest developer of drugs, trailing only the United States. In the global drug development pipeline, China’s growth rate is phenomenal, leaping from 3 per cent in 2013 to...

Events

49 h. ago Opinion | How China went from generic drug factory to biomedicine innovator

Opinion | How China went from generic drug factory to biomedicine innovator  South China Morning Post

Events

49 h. ago How China engineered the rapid rise of its drug innovation industry

China’s pharmaceutical industry is on the brink of enormous growth and transformation. In just a few years, it has moved on from being the world’s cheapest source of active pharmaceutical ingredients to becoming a major hub for pharmaceutical innovation – a place where new, more effective drugs are born. It is now the second-largest developer of drugs, trailing only the United States. In the global drug development pipeline, China’s growth rate is phenomenal, leaping from 3 per cent in 2013 to...

Events

49 h. ago Opinion | How China engineered the rapid rise of its drug innovation industry

Opinion | How China engineered the rapid rise of its drug innovation industry  South China Morning Post

Events

69 h. ago China’s move to seal records of offences like drug use sparks public backlash

Records of minor offences will be sealed under a new regulation rather than linked to a person’s identity information – a move that is proving unpopular among the public though it has been welcomed by legal experts. The new rule is part of the amended Public Security Administration Punishments Law, which was introduced in 2006 and includes minor offences such as drug use, soliciting prostitutes and minor brawls. National People’s Congress lawmakers approved the revision in June and it will take...

Events

3 d. ago China’s 3SBio seeks US$400 million in Hong Kong to boost drug pipeline

Chinese drug maker 3SBio plans to raise HK$3.12 billion (US$401 million) by selling a 4.14 per cent stake in the company to fund clinical research in China and the US and expand the global reach of its drug portfolio. The Shenyang-based biopharmaceutical firm has agreed to sell 105.1 million new shares at HK$29.62 each. The placing price represents a 6.5 per cent discount compared with Monday’s closing price of HK$31.68, according to its filing with the Hong Kong stock exchange on Tuesday. The...

Economics

2 w. ago Are Hong Kong teachers, healthcare and social workers more alert to child abuse?

Hong Kong has seen a rise in the number of potential child abuse cases reported by healthcare, education and social workers in recent years, with such professionals accounting for nearly 20 per cent of calls to a hotline, an NGO has said. Against Child Abuse chairman Patrick Cheung Chi-hung attributed the continuous rise in calls by professionals from the healthcare, education and social sectors since 2022-23 to the passing of a law making it mandatory to report suspected child abuse. “In 2024,...

Events

2 w. ago China’s clinical trial capacity matches US, attracts more global pharma firms

China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting for licensing opportunities, as the country’s clinical trial capacity has expanded to match those in the US. That assessment was made by Shanghai-based Helen Chen, Greater China managing partner at L.E.K. Consulting, one of the most respected analysts in the mainland’s life sciences industry. “There is increased interest from multinational...

Politics

2 w. ago New Report Cautions That China’s Pharma Dominance Poses Growing Risks to US Drug Supply Chain

New Report Cautions That China’s Pharma Dominance Poses Growing Risks to US Drug Supply Chain  Pharmaceutical Commerce

Events

2 w. ago America is overreliant on China for drug ingredients, a report to Congress finds

America is overreliant on China for drug ingredients, a report to Congress finds  Endpoints News

Events

3 w. ago What does Trump’s recent deal with China mean for the U.S. drug crisis?

What does Trump’s recent deal with China mean for the U.S. drug crisis?  Deseret News

Events

3 w. ago Drug war: China agrees to work with US to stop 'precursors' used to make fentanyl

Drug war: China agrees to work with US to stop 'precursors' used to make fentanyl  KFOX

Events

3 w. ago [CIIE] Simcere to Start Producing Swiss Insomnia Drug in China for Overseas Markets

[CIIE] Simcere to Start Producing Swiss Insomnia Drug in China for Overseas Markets  Yicai Global

Events

3 w. ago China Curbs Drug Precursors to North America After US Trade Deal

China Curbs Drug Precursors to North America After US Trade Deal  Bloomberg.com

Events

3 w. ago World leaders push for AI collaboration with China and shared ethical standards at Beijing Forum

World leaders push for AI collaboration with China and shared ethical standards at Beijing Forum  Global Times

Politics

4 w. ago Fierce Pharma Asia—Lilly's AI drug design deal; Celltrion's autoimmune pact; China to lift Illumina ban

Fierce Pharma Asia—Lilly's AI drug design deal; Celltrion's autoimmune pact; China to lift Illumina ban  Fierce Pharma

Events

4 w. ago Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI

Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development  PR Newswire

Politics